Abstract:Multiple sclerosis (MS) is an immune-mediated central nervous system disease mostly affecting young people. Multiple sclerosis and other neurodegenerative and white matter disorders involve oligodendrocyte (OL) damage and demyelination. Therefore, elucidating the signaling pathways involved in the remyelination process through the maturation of OL progenitor cells (OPCs) may contribute to the development of new therapeutic approaches. In this context, this paper further characterizes toxic cuprizone (CPZ)-induced demyelination and spontaneous remyelination in rats and investigates the role of ligand-dependent Notch signaling activation along demyelination/remyelination both in vivo and in vitro. Toxic treatment generated an inflammatory response characterized by both microgliosis and astrogliosis. Interestingly, early demyelination revealed an increase in the proportion of Jagged1+/GFAP+ cells, which correlated with an increase in Jagged1 transcript and concomitant Jagged1-driven Notch signaling activation, particularly in NG2+ OPCs, in both the corpus callosum (CC) and subventricular zone (SVZ). The onset of remyelination then exhibited an increase in the proportion of F3/contactin+/NG2+ cells, which correlated with an increase in F3/contactin transcript during ongoing remyelination in the CC. Moreover, neurosphere cultures revealed that neural progenitor cells present in the brain SVZ of CPZ-treated rats recapitulate in vitro the mechanisms underlying the response to toxic injury observed in vivo, compensating for mature OL loss. Altogether, the present results offer strong evidence of cell-type and ligand-specific Notch signaling activation and its time- and area-dependent participation in toxic demyelination and spontaneous remyelination.

Fractalkine enhances oligodendrocyte regeneration and remyelination in a demyelination mouse model

Anti -mouse CX3CR1 Antibody Alleviates Cognitive Impairment, Neuronal Loss and Myelin Deficits in an Animal Model of Brain Ischemia

Exogenous fractalkine enhances proliferation of endothelial cells, promotes migration of endothelial progenitor cells and improves neurological deficits in a rat model of ischemic stroke.

The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination

Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells

Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1

Preventing production of new oligodendrocytes impairs remyelination and sustains behavioural deficits after demyelination

Remyelination protects neurons from DLK-mediated neurodegeneration

Connexin 43 Deletion in Astrocytes Promotes CNS Remyelination by Modulating Local Inflammation

An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination

Circulating platelets modulate oligodendrocyte progenitor cell differentiation during remyelination

CX3CR1 modulates migration of resident microglia towards brain injury

Microglia/macrophage polarization regulates spontaneous remyelination in intermittent cuprizone model of demyelination

Accelerated Remyelination During Inflammatory Demyelination Prevents Axonal Loss and Improves Functional Recovery

Demyelination-remyelination in the Central Nervous System: Ligand-dependent Participation of the Notch Signaling Pathway

Cxcl12 Gene Therapy Ameliorates Ischemia-Induced White Matter Injury In Mouse Brain

Incomplete remyelination via endogenous or therapeutically enhanced oligodendrogenesis is sufficient to recover visual cortical function

Astrocyte-derived clusterin disrupts glial physiology to obstruct remyelination in mouse models of demyelinating diseases

Peripherally derived FGF21 promotes remyelination in the central nervous system